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Abstract. The genes coding for the two type I collagen 
chains, which are active selectively in osteoblasts, odon- 
toblasts, fibroblasts, and some mesenchymal cells, con- 
stitute good models for studying the mechanisms re- 
sponsible for the cell-specific activity of genes which 
are expressed in a small number of discrete cell types. 
To test whether separate genetic elements could direct 
the activity of the mouse pro-~l(I) collagen gene to dif- 
ferent cell types in which it is expressed, transgenic 
mice were generated harboring various fragments of 
the proximal promoter of this gene cloned upstream of 
the Escherichia coli [3-galactosidase gene. During em- 
bryonic development, X-gal staining allows for the pre- 
cise identification of the different cell types in which 
the [3-galactosidase gene is active. Transgenic mice har- 
boring 900 bp of the pro-al(I) proximal promoter ex- 
pressed the transgene at relatively low levels almost 
exclusively in skin. In mice containing 2.3 kb of this 
proximal promoter, the transgene was also expressed at 
high levels in osteoblasts and odontoblasts, but not in 
other type I collagen-producing cells. Transgenic mice 
harboring 3.2 kb of the proximal promoter showed an 
additional high level expression of the transgene in ten- 
don and fascia fibroblasts. The pattern of expression of 
the lacZ transgene directed by the 0.9- and 2.3-kb pro- 
al(I) proximal promoters was confirmed by using the 
firefly luciferase gene as a reporter gene. The pattern of 
expression of this transgene, which can be detected 
even when it is active at very low levels, paralleled that 
of the [3-galactosidase gene. These data strongly suggest 
a modular arrangement of separate cell-specific c/s-act- 
ing elements that can activate the mouse pro-a(I) col- 
lagen gene in different type I collagen-producing cells. 
At least three different types of cell-specific elements 
would be located in the first 3.2 kb of the promoter: (a) 
an element that confers low level expression in dermal 
fibroblasts; (b) a second that mediates high level ex- 
pression in osteoblasts and odontoblasts; and (c) one 
responsible for high level expression in tendon and fas- 
cia fibroblasts. Our data also imply that other cis-acting 
cell-specific elements which direct activity of the gene 
to still other type I collagen-producing cells remain to 
be identified. 
D 
IFFERENT mechanisms  can  be  envisioned  to  ac- 
count for the cell-specific  activity of a gene that is 
expressed in a small number of discrete cell types. 
A first possible mechanism is that a single type of cis-act- 
ing element recognized by a unique cell-specific transcrip- 
tion factor be present in the different cell types that are 
actively expressing  this  gene.  According to  another  hy- 
pothesis, separate cis-acting elements would be present in 
the regulatory segments of such genes and each of these 
would be recognized by distinct transcription factors spe- 
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cific for each of the cell types in which the gene is active. 
The genes for the type I collagen chains are good models 
for testing these possibilities.  Indeed, these genes are ac- 
tive in several discrete cell types, such as osteoblasts, odon- 
toblasts, and various types of fibroblasts and mesenchymal 
cells.  In case the second hypothesis were true, it would 
also be important  to begin to identify the individual ele- 
ments as a prelude to the isolation of the various lineage- 
specific transcription factors which would bind to these el- 
ements. 
Although  several  laboratories  have  generated  trans- 
genic mice harboring various regulatory segments of the 
human  and rat pro-od(I) collagen genes, the precise se- 
quences responsible for the lineage-specific expression of 
this gene have not yet been defined. These previous exper- 
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collagen minigene with a 2.3-kb promoter (Sokolov et al., 
1993) or the same human 2.3-kb DNA promoter segment 
fused to  a  growth  hormone reporter gene  (Slack et al., 
1991; Liska et al., 1994) or different lengths of the rat prox- 
imal promoter fused to the CAT gene (Pavlin et al., 1992; 
Bedalov et al., 1994; Bogdanovic et al., 1994). In mice har- 
boring  the  human  minigene,  the  levels  of  RNA  and 
polypeptides that were specified by the minigene paral- 
leled those corresponding to the endogenous gene in tail, 
bone, skin, muscle, heart, lung, intestine, kidney, and eye 
(Sokolov et al., 1993). Hence, this minigene should contain 
the sequences that were needed for approximately correct 
levels of expression in the tissues that were tested. In mice 
harboring the 2.3-kb human pro-ed(I) proximal promoter 
linked to the human growth hormone gene, a high degree 
of tissue-specific expression of the reporter was seen when 
various tissue extracts of 4-11-wk-old animals were tested 
(Slack et al.,  1991).  High levels of growth hormone RNA 
were found in bone, tail, and skin, and very low levels in 
liver, spleen, and thymus. Expression of the transgene was, 
however, not identical to that of the endogenous gene. In- 
deed, in later experiments using embryos from the same 
mice, in situ hybridization assays showed no expression of 
the  transgene  in  perichondrium  and  in  skeletal  muscle 
(Liska  et  al.,  1994),  implying that  additional  sequences 
might be needed to obtain expression of the gene in all 
type I collagen-producing cells. In newborn mice carrying 
a  3.6-kb  rat  pro-ed(I) proximal  promoter linked  to  the 
CAT gene, high levels of transgene expression were found 
in extracts of bone, tooth, and tendon; lower levels in skin; 
and no activity in liver and brain (Pavlin et al., 1992; Bog- 
danovic et al.,  1994).  In mice with a 2.3-kb rat promoter 
linked to the CAT gene, CAT enzyme levels in bone ex- 
tracts were similar to those in mice with the 3.6-kb pro- 
moter, whereas CAT enzyme levels in tendons were two 
to four times lower than in mice carrying the 3.6-kb pro- 
moter (Bogdanovic et al.,  1994).  CAT levels in skin ex- 
tracts were also substantially lower in mice harboring the 
2.3-kb promoter than in mice with  the  3.6-kb promoter 
(Bogdanovic et al., 1994).  Also, almost no transgene ex- 
pression was found in periosteal fibroblasts and aorta in 
mice harboring the 3.6-kb promoter (Pavlin et al.,  1992; 
Bedalov et al.,  1994). These experiments were consistent 
with the notion that additional elements are needed for ac- 
tivity of the  transgene  in  all  type  I  collagen-producing 
cells. 
We have used various fragments of the proximal pro- 
moter of the mouse pro-al(I)  collagen gene cloned up- 
stream  of the  E.  coli  13-galactosidase  gene  to  generate 
transgenic mice and test the hypothesis of whether sepa- 
rate elements in intact embryos could direct activity of the 
transgene in different cell types in which the endogenous 
gene  is  expressed.  The  major  advantage  of  using  the 
[3-galactosidase reporter is that X-gal staining of individual 
cells can be detected and, hence, the identity of cell types 
in which the transgene is active can be determined. More- 
over, the timing at which the transgene is activated in spe- 
cific cell types during mouse embryonic development can 
also be accurately determined and compared to the tem- 
poral and spatial activation of the endogenous gene. Our 
results indicate that distinct elements of the mouse pro- 
txl(I) collagen gene promoter direct expression of a  re- 
porter gene  to  different type I  collagen-producing cells 
during mouse embryonic development. 
Materials and Methods 
Plasmid Constructions 
Two expression vectors were used: placF contains the lacZ reporter gene, 
whereas pA31uc contains the firefly luciferase gene. In placF the lacZ 
gene is cloned upstream of the sequence of the mouse protamine gene be- 
tween +95 and +625, which supplies an intron and a polyadenylation sig- 
nal (Mercer et al., 1991). In pA31uc the firefly lnciferase gene is cloned up- 
stream of an SV40 splice site and polyadenylation signal. Moreover,  a 
polyadenylation cassette has been cloned upstream of the luciferase gene 
to prevent read-through transcription in transfection experiments (Wood 
et  al.,  1989).  Before  inserting fragment of the pro-cd(I)  collagen gene 
proximal promoter in these vectors, new unique restriction sites were in- 
troduced in the polylinkers located upstream of the lacZ gene and down- 
stream of the mouse protamine gene in placF, by standard recombinant 
techniques (placH). New unique restriction sites were also introduced in 
the polylinker located between the polyadenylation cassette and the fire- 
fly luciferase gene in pA31uc (pluc4). 
Three segments of the proximal promoter of the mouse pro<d0) col- 
lagen gene were used: a 3,260-bp fragment extending from a Kpnl site lo- 
cated 3,150 bp upstream of the start-site of transcription to an XbaI site 
located 110 bp downstream of the start site of transcription, just 5' of the 
translation initiation codon; a 2,420-bp fragment extending from a HindlII 
site located 2,310 bp upstream of the start-site of transcription to the XbaI 
site; and a  1,015-bp fragment extending from a PvuII site located 905 bp 
upstream of the start-site of transcription to the XbaI site. The 3,260-bp 
fragment was derived from pI (Harbers et al., 1984),  whereas the 2,420- 
and the  1,015-bp fragments were  derived from pG70  (Karsenty et  al., 
1990).  Each of these three fragments was cloned in the polylinker region 
of placH (32001acZ, 23001acZ, and 9001acZ, respectively), and of pluc4 
(32001ucif, 23001ucif, and 9001ucif, respectively), by standard recombinant 
techniques. A 2,954-bp matrix attachment region of the chicken lysozyme 
locus (Phi-Van and Str/itling, 1988; McKnight et al., 1992) has been cloned 
upstream  of  the  pro-cffI)  promoter  fragment  in  23001acZ,  9001acZ, 
23001ucif,  and  9001ucif  (23001acZMAR,  900lacZMAR,  23001ucifMAR, 
9001ucifMAR, respectively) by standard recombinant techniques. 
Generation of Transgenic Mice 
Before injection, the constructs were  digested with restriction enzymes 
cutting immediately downstream of the polyadenylation signal and up- 
stream of either the pro-al(I)  collagen gene sequences or the chicken 
lysozyme matrix attachment region locus. The inserts were separated from 
the vectors by electrophoresis on agarose gel, and recovered by electro- 
elution. The solution containing the DNA was extracted twice with phe- 
nol/chloroform/isoamylalcohol, and once with chloroform/isoamylalcohol. 
After ethanol precipitation and two 70% ethanol washes, the DNA was 
redissolved in 5 mM Tris-HC1 (pH 7.4), 0.1 mM EDTA (pH 8.0), 5 mM 
NaCI. When lacZ constructs were injected alone, the DNA was dissolved 
at a concentration of 2 ng/~l. When both lacZ containing and luciferase 
gene containing constructs were coinjected, each DNA was dissolved at a 
concentration of 1.5 ng/pA. DNAs were injected into pronuclei of mouse 
B 6 × D2F  2 fertilized eggs by standard procedures (Hogan et al., 1986). The 
injected eggs were then transferred into CD1 foster mothers. The integra- 
tion of the transgene(s) in the genome of founder mice was assessed by 
Southern blot analysis of either tail DNA or placenta DNA. 12 mice out 
of a total of 37 mice which were positive by Southern blot analysis showed 
no X-gal staining in whole embryos and had no luciferase activity. 
Southern Blot Analysis 
Genomic DNA was isolated from tail or placenta by standard procedures 
(Sambrook  et  al.,  1989).  15  ~g of DNA were  digested overnight with 
EcoRI and XbaI. The DNA was then separated by electrophoresis on a 
0.8%  agarose gel. After denaturation, the DNA fragments were  trans- 
ferred to a nylon membrane (Zeta-Probe GT; Bio-Rad Laboratories, Her- 
cules, CA), which was hybridized overnight with both a  lacZ and a  lu- 
ciferase DNA probe. The filter was then washed in 2 ×  SSC, 0.1% SDS 
(1  ×  SSC is 0.15 M  NaC1 plus 0.015  M  sodium citrate). The probes used 
The Journal of Cell Biology, Volume 129, 1995  1422 were a 3-kb lacZ fragment (obtained by digestion of pLacH with EcoRI), 
and  a  1.1-kb  luciferase fragment (obtained by digestion of pluc4  with 
EcoRI and XbaI). Each probe was radiolabeled with [32p]udCTP  using a 
random primed DNA  labeling kit  (Boehringer Mannheim, Mannheim, 
Germany). 
fl-Galactosidase Expression 
13-galactosidase  activity was assessed on embryos and newborn mice as 
previously described (Mercer et al., 1991). Briefly, embryos were fixed for 
30--40 min in 0.1 M NaPO4 (pH 7.3), 2% formalin, 0.2% glutaraldehyde, 5 
mM EGTA, and 2 mM MgCI2. After washing, they were stained overnight 
with X-gal (1 mg/ml) in PBS containing 2 mM MgCI2, 4 mM potassium 
ferrocyanide, 5  mM potassium ferricyanide, 0.2%  (vol/vol) NP-40,  and 
0.1% sodium deoxycholate. For embryos older than 16.5 d post concep- 
tion (p.c.),  1 the skin was removed before fixation. After staining, the em- 
bryos were washed in PBS and photographed. Some 18.5 d p.c. embryos 
were partially clarified in potassium hydroxide (McLeod, 1980) before be- 
ing photographed. For histology, embryos were dehydrated in ethanol, 
and embedded in paraffin. 8-p~m-thick sections were sliced on a  micro- 
tome and counterstained with eosin. 
Luciferase Expression 
Luciferase activity was assessed in 4-wk-old mice. Organs were homoge- 
nized in 500 ~1 of solution A containing 0.1 M KPO4 (pH 7.8), 1 mM DTF, 
1. Abbreviation used in this paper, p.c., post conception. 
and then submitted to a freeze/thaw procedure. After centrifugation, 100 
p~l of the supernatant were diluted with 250 p,l of solution B  containing 
0.1 M  KPO4 (pH 7.8),  15 mM MgSO4, 5 mM ATP, 1 mM DTr. The lu- 
ciferase activity was measured in this 350-1zl sample in the presence of an 
excess of D  luciferin (0.07  mg/mi) by using a  luminometer (Monolight- 
2010; Analytical Luminescence Laboratory, San Diego, CA). Protein lev- 
els were measured by the Bradford assay (Bradford et al., 1976). Results 
were expressed as luciferase light units per 1 mg of protein. The amounts 
of protein contained in tissue samples homogenized in solution A  were 
slightly variable from one experiment to the other, but average amounts 
(mean --- SEM) were: 4.5  +_ 0.2 mg/ml for tail, 6.2 _+ 0.4 mg/ml for bone, 
0.07 -  0.01 mg/ml for tooth, 3.4 -+ 0.2 mg/ml for skin, 0.8 -+ 0.08 mg/ml for 
tendon, 20.8 -  3.8 mg/ml for muscle, 28.3 --- 4.6 mg/ml for heart, 7.7 _+ 0.6 
mg/ml for lung, 10.1  --- 0.7  mg/ml for peritoneum, 1.0  -+ 0.2  mg/rul for 
aorta, 7.5 -+ 0.7 mg/ml for intestine, 57.4 _+ 4.4 mg/ml for liver, 29.6  _+ 5.3 
mg/lg for spleen, 41.2 _+ 4.1 mg/ml for kidney, 4.9 ±  0.8 mg/ml for thymus, 
28.8  --- 4.1 mg/ml for brain. Background values, obtained by measuring 
100 Ixl of buffer A diluted to 350 I~1 with buffer B were comprised between 
130 and 240 light units (177  -+ 11).  Raw values less than 100 light units 
above background, were considered as not significantly different from 
background, and reported as undetectable. 
Results 
Generation of Transgenic Mice 
Transgenic  mice  were  generated  by  microinjecting  the 
following constructs  (Fig. 1) into fertilized  oocytes: (a) si- 
Figure  1.  Schematic  repre- 
sentation of DNA  constructs 
used  to  generate  transgenic 
mice.  See  Materials  and 
Methods  for  details.  MAR, 
matrix  attachment  region  of 
the chicken lysozyme gene. 
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simultaneous microinjection of 23001acZMAR and 23001ucif- 
MAR;  (c)  simultaneous microinjection of 900lacZMAR 
and 9001ucifMAR;  and (d) 32001acZ. For each construct, 
Southern blot analyses identified the mice that had inte- 
grated the transgene(s)  and the approximate number of 
copies of each transgene. Table  I  shows the number of 
copies of the transgenes, in all founder mice or lines ex- 
pressing the transgene(s), as determined by either X-gal 
staining or measurement of luciferase activity. 
The histochemical stain for [3-galactosidase,  X-gal, pro- 
vides considerable detail about the type of cells in which 
the cloned regulatory sequences are active and about the 
stage of embryonic development at which these sequences 
become  active.  The  luciferase reporter  provides  a  very 
sensitive assay that allows quantitative determination of 
the product of the transgene in various tissue extracts. It 
was used to confirm that the absence of X-gal staining in 
some cell types was not the results of a lack of sensitivity 
of the X-gal assay. 
Transgenic Mice for 23001acZ, 
23001ucif,  23001acZ MAR, and 23001ucifMAR 
We  first  used  2.3  kb  of the  proximal  promoter  of the 
mouse pro-al(I) collagen gene cloned upstream of either 
the lacZ gene or the luciferase gene (23001acZ and 2300- 
lucif,  respectively)  to  generate  transgenic  mice.  Seven 
transgenic mouse lines that expressed either [3-galactosi- 
dase or luciferase were generated (Table I). Among these, 
four lines (lines 1.33, 1.35, 1.46, 1.49) had integrated both 
transgenes; two (lines 1.2, 1.13) had integrated only 2300- 
lacZ; and one (line 1.50) integrated only 23001ucif. 
In all six lines expressing [3-galactosidase,  an identical 
pattern of X-gal staining was observed during embryonic 
development.  No  [3-galactosidase  activity could  be  de- 
tected until 13 d p.c. (Fig. 2 A). Thereafter, starting be- 
tween 13 and 14 d p.c., a very close spatial and temporal 
correlation was observed between the expression of the 
transgene (Fig. 2, B-D) and bone ossification determined 
by alizarin staining (Kaufman, 1992). Histological sections 
of embryos at various times of development confirmed the 
close spatial and temporal correlation between expression 
of the  transgene and  osteoblast differentiation (Fig. 2, 
E-/). Whereas osteoblasts were stained by X-gal (Fig. 2, 
E-H), no staining was seen in chondrocytes (Fig. 2, E, G, 
and I), condensed mesenchymal cells (data not shown), 
perichondrial or periosteal fibroblasts (Fig. 2, E, F, H, and 
/). In addition to osteoblast staining, histological sections 
performed either during the last four days of embryonic 
development or in newborn mice also showed a strong ex- 
pression of the transgene in odontoblasts (Fig. 2 J), which 
synthesize high levels of type I collagen. Other dental cells 
that do not synthesize type I collagen, such as ameloblasts, 
were not stained (Fig. 2 J). Expression of the transgene in 
odontoblasts was also temporally regulated in parallel to 
expression of the endogenous gene. For example, staining 
of odontoblasts was detected at 16.5 d p.c. in incisors, but 
only 3 d later in first molars, which parallels data obtained 
by in situ hybridization (Schwarz et al., 1990). Finally, faint 
X-gal staining of the skin appeared at 16.5 d p.c. in whole- 
mount embryos (data not shown). This staining was, how- 
ever, too faint to be detected by histology. There was no 
staining of the other fibroblast-rich tissues in any of the six 
lines, both in whole embryo and in histological sections. 
For example, connective tissue fascia (Fig. 2 H), tendons 
(Fig. 2/), muscle fibroblasts (Fig. 2, E and F), heart valves, 
or organ capsules  (data not shown) were all completely 
negative, whereas in situ hybridization using a pro-al(I) 
probe showed a strong signal in these tissues (K. Nieder- 
reither, R. D'Souza, M. Metsaranta, H. Eberspaecher, E. 
Vuorio, B. de Crombrugghe, manuscript in preparation). 
With the exception of line 1.49, which showed some faint 
staining in the brain (data not shown), there was no pro- 
miscuous expression of the lacZ gene in tissues or cells not 
producing type I collagen. We conclude from these experi- 
ments that the 2,300-bp  pro-al(I) collagen proximal pro- 
moter was highly active in osteoblasts and odontoblasts, 
faintly active in skin, and inactive in other cell types in- 
cluding fibroblasts of other tissues. 
In tissue extracts of five lines expressing the luciferase 
transgene, enzyme activity was measured in one-month- 
old pups (Table II). Despite the sensitivity of this assay, 
there  was  no  or  almost no  luciferase  activity in  tissues 
Table I. Copy Number of the Transgenes in Mouse Lines or Founder Mice Expressing fl-Galactosidase and~or  Luciferase 
Copy no.  Copy no. 
Construct  Line  lacZ  Luciferase  Construct  Line  lacZ  Luciferase 
23001acZ  1.2  3-5  0  900lacZMar  2.10  5-7  1-3 
23001ucif  1.13  15-20  0  9001ucifMAR  2.13  8-10  0 
1.33  10-15  1-3  2.15  1-3  5-7 
1.35  10-15  3-5  2.23  5-7  0 
1.46  1-3  1-3  2.26  3-5  5-7 
1.49  3-5  3-5  2.30  8-10  8-10 
1.50  0  1-3  2.31  3-5  1-3 
23001acZMAR  7.9  3-5  3-5  32001acZ  5.1 *  3-5 
23001ucifMAR  7.14  1-3  1-3  5.2"  5-7 
7.17  5-7  0  5.14"  10-15 
7.32  0  1-3  5.30  8-10 
5.41  1-3 
5.43  8-10 
5.54  10-15 
* Founder was sacrificed. 
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staining such as muscle, heart, lung, peritoneum, aorta, or 
intestine (less than 0.1% of the luciferase activity in tail). 
The only exception was a very low luciferase activity in the 
tendons of the tail in four of five lines. This activity was 
100-500z  lower than  the  luciferase activity detected in 
complete tails and could be a result of a low level of con- 
tamination  by  osteoblasts  of tail  vertebrae.  Indeed,  we 
never detected any X-gal staining of tendon fibroblasts in 
mice harboring  a  2,300-bp pro-ed(I) collagen promoter. 
As expected from the pattern of expression of the 13-galac- 
tosidase gene, high levels of luciferase activity were ob- 
served in bone, and in teeth. In all lines there was also a 
low level of luciferase activity in skin. Although this skin 
value was low compared to the luciferase value in bone, it 
was  always at least 20x  higher than the background lu- 
ciferase values. 
The expression of the luciferase gene was highly tissue 
specific. In four lines (1.33,  1.35, 1.46,  1.49),  no or almost 
no luciferase activity could be detected in organs such as 
liver, spleen, kidney, and thymus, which are known to con- 
tain very little type I  collagen RNA  (Slack et al.,  1991; 
Goldberg et al., 1992). Line 1.50 displayed some luciferase 
activity in these organs, but it was always very low, more 
than 5,000x  lower than in tail. In all five lines, some lu- 
ciferase could be detected in the brain, but it too was al- 
ways extremely low. The differences in absolute luciferase 
values between the different mouse lines are probably due 
to differences in sites of integration of the transgene. De- 
spite  these  differences the  pattern  of expression  of the 
transgene is remarkably similar in the different lines. 
In  conclusion,  the  very  sensitive  luciferase  measure- 
ments in  1-mo-old animals were in complete agreement 
with the results of X-gal staining and confirmed that the 
pattern of expression of the transgene was much more re- 
stricted than that of the endogenous gene. 
The so-called matrix attachment region of the chicken 
lysozyme locus has previously been shown to increase the 
proportion of mice expressing a transgene, and to allow a 
more faithful developmental regulation of the transgene 
(McKnight et al.,  1992).  To test whether this DNA seg- 
ment might also cause expression of the transgene in type 
I  collagen-producing  cells  other  than  osteoblasts  and 
odontoblasts, we cloned the chicken lysozyme gene matrix 
attachment region upstream of the promoter of the pro- 
ed(I) collagen gene both in 23001acZ and in 23001ucif. Be- 
cause the copies of the transgene mostly integrate in the 
genome as tandem repeats in a head-to-tail configuration, 
we reasoned that all transgene copies, with the possible ex- 
ception of the most 3' or 5' ones, would be separated from 
neighboring sequences in the genome by a matrix-attach- 
ment  region.  Four  lines  were  generated  that  expressed 
13-galactosidase  and/or  luciferase  (Table  I).  Two  lines 
harbored  both  transgenes,  one  contained  only  2300- 
lacZMAR, and one contained only 23001ucifMAR. 
In all cases, the pattern of expression of the lacZ gene 
was identical to the one described for 23001acZ (data not 
shown). The transgene was expressed at high levels only 
by  osteoblasts  and  odontoblasts.  There  was  faint  skin 
staining  visible at  16.5  d  p.c. No X-gal  staining  was  de- 
tected in other tissues, including connective tissue fascia, 
tendons,  heart  valves,  organ  capsules,  blood vessels,  or 
muscle fibroblasts. The temporal expression of the trans- 
gene during embryonic development was identical to the 
one described for the lines expressing 23001acZ, which did 
not contain the chicken lysozyme gene matrix-attachment 
region. 
The pattern of expression of the luciferase gene was also 
similar to the one described for mice harboring 23001ucif 
(Table III).  It was  expressed at high levels in bone and 
teeth and  at  lower levels in skin.  Although the  skin lu- 
ciferase values  were  generally higher in  the  three  lines 
containing 23001ucifMAR than  in  the  lines  of Table II, 
these differences are not statistically significant. It was also 
not or almost not expressed in muscle, heart, lung, perito- 
neum,  aorta,  and intestine  (at least  1,O00x  tess than in 
tail).  There  was  little  or  no  luciferase  activity  in  liver, 
spleen, kidney, thymus, and brain. 
We conclude from these experiments that the presence 
of the  matrix-attachment region from the  chicken lyso- 
Table II. Luciferase Activity in Tissue Extracts of One-Month-Old Transgenic Mice Harboring 23001ucif 
Line 1.33  Line !.35  Line 1.46  Line 1.49  Line 1.50 
Tail  1042 (100)*  9525 (100)  110 (100)  1430 (100)  11783 (100) 
Bone  1970 (189)  10198 (107)  163 (147)  1725 (121)  14271 (121) 
Tooth  1732 (166)  18621 (195)  94 (85)  2043  (143)  10478 (89) 
Skin  7 (0.7)  48 (0.5)  0.8 (0.7)  42 (3)  957 (8) 
Tendon  4 (0.4)  18 (0.2)  und:~  3 (0.2)  123 (1) 
Muscle  und  und  und  und  7 (0.06) 
Heart  0.02  und  und  und  3 (0.02) 
Lung  0.1  und  und  und  0.7 
Peritoneum  und  0.5  und  und  8 (0.07) 
Aorta  1 (0.1)  und  und  und  6 (0.05) 
Intestine  und  0.6  und  und  0.2 
Liver  und  und  und  und  0.08 
Spleen  und  und  und  und  1 
Kidney  und  und  und  und  0.2 
Thymus  0.2 (0.03)  und  und  und  2 (0.02) 
Brain  1 (0.1)  0.1  0.3 (0.3)  0.1  7 (0.06) 
* Luciferase activities are expressed  as 103 light units/mg  protein. Values in parentheses  represent  percent of the luciferase activity in 
dicated. 
$ und, undetectable (i.e., not significantly different from values obtained with buffer alone). 
tail; percent values below 0.01% are not in- 
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expression of the transgene in different tissues and did not 
cause activation of the transgene in fibroblastic or mesen- 
chymal cells. 
Transgenic Mice  for 9001acZMAR and 9001ucifMAR 
To further delineate the region of the pro-od(I) promoter 
responsible for the pattern of expression described above, 
we generated transgenic mice harboring only 905 bp of the 
proximal pro-al(I)  promoter cloned  upstream  of either 
the lacZ or the luciferase genes. In each construction, the 
matrix attachment  region  of the  chicken  lysozyme gene 
was  cloned  upstream  of  the  pro-al(I)  promoter.  Five 
transgenic  lines  expressed  both transgenes,  and  two  ex- 
pressed only 900lacZMAR (Table I). 
No X-gal staining was detected in lines 2.13,  2.23, 2.26, 
2.30, and 2.31 before 16.5 d p.c. (data not shown). At 16.5 d 
p.c., a faint skin staining similar to the one observed with 
23001acZ  and  23001acZMAR  was  detected  in  whole- 
mount embryos (Fig. 3, A  and B). This faint X-gal staining 
could not, however, be detected by light microscopy after 
histological sectioning. No osteoblast or odontob.last stain- 
ing was detected either in whole-mount embryos or by his- 
tology. 
As shown in Table IV, three lines (2.26, 2.30,  2.31) dis- 
played  a  similar  tissue  pattern  of luciferase  expression. 
The  transgene  was  expressed  in  skin  whereas  very low 
levels of luciferase activity were found in bone. The raw 
values in skin were at least 400x higher than background 
values (P =  0.01). Low levels of luciferase were found in 
the tendons of the tail, and no or almost no activity was 
found in organs such as muscle, heart, lung, peritoneum, 
aorta, or intestine (at least 1,000x  less than in tail). There 
was also almost no luciferase activity in organs expressing 
the pro-txl(I) gene at very low levels such as liver, spleen, 
kidney, thymus, or brain. 
Two of the lines that contained both 13-galactosidase and 
luciferase transgenes  (lines 2.10 and 2.15)  showed widely 
promiscuous expression of these reporter genes (data not 
shown). Hence, the presence of the matrix attachment re- 
gion DNA segment in the transgenic constructions did not 
prevent promiscuous expression of the transgene. 
It thus appears that the 905-bp segment of the proximal 
pro-txl(I) promoter was able to direct tissue-specific ex- 
pression of the transgenes. Indeed, both transgenes were 
expressed in skin but not in bone or teeth. Together with 
the pattern of expression of mice carrying a 2,300-bp pro- 
moter  fragment,  these  results  suggest  that  different  re- 
gions of the pro-ed(I) promoter can direCt expression of 
reporter genes in osteoblasts and in skin fibroblasts. 
Table IlL Luciferase Activity in Tissue Extracts of 
One-Month-Old Transgenic Mice Harboring 23001ucifMAR 
Line 7.9  Line 7.14  Line 7.32 
Tail  408 (100)*  1437 (100)  11136 (100) 
Bone  654 (160)  2440 (170)  46859 (420) 
Tooth  1021 (250)  2808 (195)  31175 (280) 
Skin  143 (35)  273 (19)  612 (5) 
Tendon  7 (2)  69 (5)  133 (1) 
Muscle  und:~  trod  4 (0.03) 
Heart  und  0.06  2 (0.02) 
Lung  und  und  und 
Peritoneum  und  und  2 (0.02) 
Aorta  und  1 (0.07)  9 (0.08) 
Intestine  0.6 (0.1)  und  1 
Liver  und  und  und 
Spleen  und  und  0.1 
Kidney  0.02  und  0.04 
Thymus  1 (0.2)  und  4 (0.03) 
Brain  0.2 (0.05)  0.4 (0.03)  3 (0.03) 
* Luciferase activities are expressed as 103 light units/mg protein. Values in parenthe- 
ses represent percent of the luciferase activity in tail; percent values below 0.01% are 
not indicated. 
:~ und, undetectable (i.e., not significantly different from values obtained with buffer 
alone). 
Transgenic Mice for 32001acZ 
To determine  if additional  tissue-specific elements were 
located upstream of the first 2.3  kb of the promoter, we 
cloned 3150 bp of the promoter in the lacZ vector (3200- 
lacZ) to generate transgenic mice, extending the promoter 
by 850 bp. Seven transgenic mice expressing [3-galactosi- 
dase were obtained (Table I). Three were sacrificed and 
stained at 15.5 d of embryonic development, and four were 
used to generate transgenic lines. 
As for mice harboring 2,300 bp of the pro-~l(I) proxi- 
mal promoter, we observed X-gal staining of ossification 
centers in whole-mount embryos in all cases (Fig. 4, A, C, 
and  D).  This  staining  could  be detected  after a  shorter 
incubation  with  X-gal  than  for  the  lines  transgenic  for 
23001acZ, and 23001acZMAR  (a few hours compared to 
overnight). Histological sections confirmed osteoblast stain- 
ing (Fig.  4,  E-G)  and  also showed  odontoblast  staining 
during the last four days of embryonic development (data 
not shown). The staining of these tissues was more intense 
than for the mice harboring only 2,300 bp of the promoter 
(compare Fig. 4 F with Fig. 2 F) suggesting the presence of 
an enhancing element which increases expression in osteo- 
blasts  and  odontoblasts  located  between  -2,300  and 
-3,200 bp. There was also a faint skin staining in whole- 
mount embryos, appearing at 16.5 d p.c. (data not shown), 
but as for the other constructs, this skin staining could not 
be detected by histology. 
Figure 2.  Expression of the lacZ gene in embryos or newborn mice transgenic  for 23001acZ, as indicated  by blue X-gal stain. (,4) Ab- 
sence of X-gal staining in a 13 d p.c. whole-mount embryo (line 1.35). (B-D) 14.5, 15.5, 18.5 d p.c. whole-mount embryos, respectively, 
showing staining of ossification centers (line 1.35); in (D), the embryo has been partially clarified with potassium hydroxide after X-gal 
staining; staining of intestine  (arrows) in (D) is due to endogenous 13-galactosidase. (E) Transverse section of a forelimb at 14.5 d p.c. 
showing expression of the lacZ gene in osteoblasts, but not in chondrocytes,  perichondrial  and muscle fibroblasts  (line 1.13). (F) Trans- 
verse section of a hindlimb at 16.5 d p.c. showing X-gal staining of osteoblasts but not of muscle fibroblasts (line 1.35). (G) Longitudinal 
section of a growth plate at birth, with staining restricted to osteoblasts (line 1.35). (H) Sagittal section of a head at 15.5 d p.c. showing 
staining of osteoblasts (line 1.2). (/) On a sagittal section of tail at 16.5 d p.c. (line 1.49), there is no staining of chondrocytes,  perichon- 
drial fibroblasts, or tendons fibroblasts.  (J) Longitudinal  section of an upper incisor at birth (line 1.35) showing staining of odontoblasts 
(od) and of mandibular osteoblasts (ost), but not of ameloblasts (am). Bars, 200 p~m. 
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cates expression of the transgene, is faint and restricted to the skin. (B) Higher magnification of the skin. 
In addition to this expected pattern of expression of the 
transgene, and as suspected from whole-mount embryos 
(Fig. 4, A-D), histological sections showed a  staining of 
ligaments and tendons in all cases (Fig. 4, G-/). This stain- 
ing was detected beginning at 14.5 d p.c. in tendons of the 
limbs (Fig. 4 A) and two days later in tendons of the tail 
(Fig. 4 B). Finally, histological sections showed staining of 
fibroblasts forming the connective tissue fascia (Fig. 4, E 
and J), appearing at 13 d p.c. No X-gal staining was seen, 
however, in tissues like organ capsules (Fig. 4 J), lung (Fig. 
4 J), muscle fibroblasts (Fig. 4 F), or cardiac valves. There 
was also no staining of the perichondrium (Fig. 4,  G-/). 
These data suggest that an element located between 2,300 
and 3,200 bp upstream of the start site of transcription is 
important for activating expression of the lacZ transgene 
specifically in tendon and fascia fibroblasts. 
Discussion 
The experiments presented here strongly suggest the no- 
tion that different cis-acting cell-specific elements exist in 
the pro-txl(I) collagen promoter which control the expres- 
sion of this  gene  in  different type I  collagen-producing 
cells during embryonic development. This model is based 
on the high degree of specificity of X-gal staining, which 
allows  clear  identification  of  the  specific  cell  types  in 
which the transgene is active, and on identical spatial and 
temporal patterns of X-gal staining at various stages dur- 
ing  embryonic development  in  several  mice  strains  for 
each construction. The very sensitive measurements of lu- 
ciferase enzyme activities assayed in extracts of tissues on 
one-month-old transgenic mice supported similar conclu- 
sions. 
Transgenic mice harboring 900 bp of the pro-cd (i) prox- 
imal promoter  expressed  low levels of the lacZ and lu- 
Table IV. Luciferase Activity in Tissue Extracts of 
One-Month-Old Transgenic Mice Harboring 9001ucifMAR 
Line 2.26  Line 2.30  Line 2.31 
Tail  209 (100)*  101 (100)  85 (100) 
Bone:~  1 (0.5)  2 (2)  1 (1) 
Tooth  und§  und  und 
Skin  632 (302)  384 (384)  181 (213) 
Tendon:[:  1 (0.5)  14 (14)  8 (9) 
Muscle  und  und  0.1 (0.1) 
Heart  und  und  und 
Lung  0.3 (0.1)  und  und 
Peritoneum:~  und  0.1 (0.1)  0.1 (0.1) 
Aorta  und  und  und 
Intestine  und  und  und 
Liver~  0.05 (0.02)  0.05 (0.05)  0.03 (0.03) 
Spleen  und  und  und 
Kidney  und  0.02 (0.02)  und 
Thymus:~  0.3 (0~ 1)  0.4 (0.4)  und 
Brain:~  0.1 (0.05)  0.07 (0.07)  2 (2) 
* Luciferase activities are expressed as 103 light units/rag protein. Values in parenthe- 
ses represent percent of the luciferase activity in tail. 
:~ Values statistically significantly lower than skin values (P <  0.05, with unpaired 
Student' s t test). 
§ und, undetectable (i,e., not significantly different from values obtained with buffer 
alone). 
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genic mice  containing 2.3  kb  of the  proximal promoter 
expressed the transgene at high levels in osteoblasts and 
odontoblasts, at low levels in skin, but not in other type I 
collagen-producing cells. In these mice, activation of the 
transgene in osteoblasts started around day 13.5 p.c. and 
coincided with  the  developmental appearance  of osteo- 
blasts in various ossification centers. Similarly, activation 
of the transgene in odontoblasts followed the same devel- 
opmental pattern as that of odontoblasts themselves dur- 
ing the  formation of different teeth  organs.  Transgenic 
mice harboring 3.2 kb of the pro-al(I) proximal promoter 
expressed the lacZ reporter gene at high levels in osteo- 
blasts and odontoblasts as well as in tendon and fascia fi- 
broblasts and at low levels in skin (see Fig. 5). Taken to- 
gether, these data strongly suggest a modular arrangement 
of separate cell-specific cis-acting  elements that can acti- 
vate the pro-ed(I) collagen gene in different type I  col- 
lagen-producing cells. At least three different types of cell- 
specific elements would be located in the first 3.2 kb of the 
pro-txl(I) promoter: (a) an element the confers a low level 
expression of the transgene in dermal fibroblasts, located 
in the proximal 900 bp of the promoter; (b) an element 
that mediates high level expression of the gene in osteo- 
blasts and odontoblasts, located between -2,300 and -900 
bp; and (c) an element needed for high level expression of 
the gene in tendon and fascia fibroblasts, located between 
-3,200 and -2,300 bp. 
We have recently further delineated the osteoblast ele- 
ment to a much smaller 120-bp fragment which in conjunc- 
tion with a  220-bp proal(I) promoter confers high level 
osteoblast  specificity  (J.  Rossert,  unpublished  observa- 
tion). The segment between  -3,200 and  -2,300 bp also 
appears to increase promoter activity in osteoblasts  and 
odontoblasts above the level observed with the -2,300 bp 
promoter. This could be due to the presence of an addi- 
tional osteoblast/odontoblast-specific element in this  se- 
quence. Alternatively, since the tendon enhancer might be 
composed of both DNA binding sites for ubiquitous tran- 
scription factors and  for a  tendon-specific element, it is 
possible that the activity of the osteoblast/odontoblast ele- 
ment between -900 and -2,300 bp could be increased by 
ubiquitous factors binding more upstream. 
Our results could also be consistent with the existence of 
elements within the 2.3-kb proximal promoter that would 
cooperate  with  the  tendon  element  between  -3.2  and 
-2.3 kb to confer high level transgene activity in tendon fi- 
broblasts.  Our results suggest that if such elements exist 
within the 2.3-kb segment, they are unable by themselves 
to direct expression in tendon fibroblasts. 
Our data further suggest that still other cis-acting  cell- 
specific elements remain to be identified. For example, in 
none of our mice was there expression of the transgenes in 
perichondrium, skeletal muscle, aorta, or organ capsules. 
Our data are also consistent with the possibility that ele- 
ments similar to those observed here are present in other 
parts of the gene that were not examined in this study. 
Among the  eight lines  harboring the 2.3-kb pro-al(I) 
collagen gene proximal promoter cloned upstream of the 
luciferase gene, six lines showed levels of expression of the 
reporter gene in tail between 106 and 12 ×  106 luciferase 
light units per mg of protein. Two lines had lower levels of 
luciferase activity (105 and 4 ×  105 luciferase light units per 
mg of protein for lines  1.46  and 7.9,  respectively). This 
variability in the levels of expression reflects a very poorly 
understood phenomenon known as site of integration ef- 
fect. Interestingly, however, the patterns of expression of 
the reporter genes were the same for the two low express- 
ing lines as for the other six. 
Previous data obtained with transgenic mice for the hu- 
man and the rat pro-al(I) collagen gene were also consis- 
tent with  such a  modular  arrangement of different cell- 
specific regulatory elements. With the human gene, 2.3 kb 
of the proximal pro-al(I) promoter directed high levels of 
expression of a reporter gene in bone and tendon but not 
in perichondrial fibroblasts or skeletal muscle (Liska et al., 
1994).  With  the  rat  gene, mice  harboring  a  3.6-kb  pro- 
ed(I)  proximal  promoter cloned upstream  of the  CAT 
gene expressed the transgene at high levels in bone, teeth 
and tendons but not in aorta or in perichondrial fibroblasts 
(Pavlin et al., 1992; Bedalov et al., 1994; Bogdanovic et al., 
1994). In all three species, the element(s) responsible for 
high level expression of the transgene in bone appears to 
be located within the first 2.3 kb of the promoter (Slack et 
al., 1991; Bogdanovic et al.,  1994; Liska et al.,  1994). The 
cis-acting  segments responsible for high level expression 
of the  gene in tendon fibroblasts are located within the 
first 2.3 kb of the human proximal promoter (Liska et al., 
1994). In mice our results show that an element important 
for the expression of the pro-al(I) gene in tendon fibro- 
blasts is located between -3.2 and -2.3 kb, but we cannot 
rule out that this element cooperates with other ones lo- 
cated downstream of -2.3 kb. Results using the rat pro- 
moter are consistent with the notion that elements located 
between -1.7 and -2.3 kb and between -2.3 and -3.6 kb 
are involved in the expression of the pro-al(I) gene in ten- 
don fibroblasts in this species (Bogdanovic et al.,  1994). 
Alternatively,  it  is  possible  that  measurements  of  the 
transgene-encoded CAT  enzyme in tendons might have 
been contaminated with CAT enzyme from osteoblasts, as 
would likely occur in extracts of tail, and that in rats an im- 
portant cis-acting element that directs activity of the pro.- 
etl(I) gene in tendons has the same location as in mice'. 
The location of an element responsible for expression of 
the transgene in skin does not seem to be the same in rat 
and in mouse. In the rat promoter, such an element ap- 
pears to be located upstream of -1.7 kb (Bogdanovic et 
al., 1994), whereas in the mouse promoter, one such ele- 
ment is located within the proximal 0.9 kb. These discrep- 
ancies suggest the possibility of different arrangements of 
regulatory sequences within the pro-ed(I) promoter in dif- 
ferent species. 
In  our  experiments  the  transgenes  were  always  ex- 
pressed at low levels in skin, suggesting that a cooperativ- 
ity with other elements is required to obtain high levels of 
expression in skin fibroblasts. Such elements could be lo- 
cated in the first intron since deletion of most of the first 
intron from a  construction containing the human  2.3-kb 
pro-etl(I)  promoter  strongly  decreased  expression  of  a 
growth hormone reporter gene in dermal and fascial fibro- 
blasts of 17-d p.c. embryos as assayed by in situ hybridiza- 
tion (Liska et al., 1994).  However, this difference was not 
clearly observed when measurements of growth hormone 
mRNA were performed in extracts of full thickness skin 
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biopsies of the same animals at 4 to 11 weeks of age, using 
a method that was less discriminating than in situ hybrid- 
ization (Slack et al., 1991). Another report showed that, in 
mice harboring  a  human pro-or(I) procollagen minigene, 
the pattern of expression of the tran~gene was not differ- 
ent from those carrying the same minigene with most of 
the first intron deleted (Sokolov et al., 1993). Also, the tis- 
sue-specific expression of a CAT reporter gene linked to 
the  3.6-kb  rat  proximal promoter was  identical,  with  or 
without  most  of the  first  intron  (Bedalov  et  al.,  1994). 
Hence it appears that the effect of the first intron in trans- 
genic mice is complex, might be species dependent,  and 
might need methods providing greater histological detail 
to be detected. 
The Movl3 mouse strain is characterized by an insertion 
of a 9-kb Moloney murine leukemia retroviral sequence in 
the first intron of the pro-al(I) collagen gene (Harbers et 
al., 1984).  This retroviral DNA insertion has been shown 
to prevent the initiation  of transcription of the pro-od(I) 
procollagen gene in fibroblastic cells (Hartung et al., 1986) 
but did not prevent the presence of pro-txl(I) RNA in os- 
teoblasts  nor  in  odontoblasts  (Kratochwil  et  al.,  1989; 
Schwarz et al., 1990). This observation was consistent with 
the idea that transcription of the pro-al(I) collagen gene 
was controlled by different cis-regulatory  sequences in fi- 
broblasts and in osteoblasts and odontoblasts. Our results 
support this hypothesis. 
Evidence exists that the coordinate synthesis in a 2:1 ra- 
tio of the ctl and et2 chains of type I collagen occurs at the 
level of transcription (Bornstein and Sage, 1989), strongly 
suggesting that the  same molecular mechanisms activate 
both genes. Studies in transgenic mice have indicated that 
the 2,000-bp sequence upstream of the start of transcrip- 
tion  of the  mouse pro-a2(I) collagen  gene contains  ele- 
ments that  are sufficient for expression of a  B-galactosi- 
dase  transgene  in  most  type  I  collagen-containing  cells 
(Niederreither et al.,  1992).  Similarly, a  350-bp proximal 
promoter was also active in many of the same cells (Nie- 
derreither et al., 1992), although this 350-bp promoter ap- 
peared to be considerably weaker than the 2,000-bp pro- 
moter, and its expression in osteoblasts barely detectable; 
this could suggest the possibility that the segment between 
-350 and -2,000 bp in the pro-ot2(I) promoter contains an 
osteoblast-specific element.  These results  and those pre- 
sented here suggest that the  arrangement of cell-specific 
regulatory elements is different in the two type I collagen 
genes.  We  also  believe  that  other  elements  outside  the 
2,000-bp  proximal  promoter  in  the  pro-a2(I)  gene  are 
needed  for  fully  activity  of  this  gene.  Studies  are  in 
progress to identify such elements and compare them with 
similar elements in the pro-ed(I) collagen gene. 
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